Som et resultat af foranstaltninger, der blev gennemført i 2005, forsyner agenturet nu offentligheden med en bredere vifte af information om de lægemidler, som agenturet vurderer.
In addition to summaries of opinions, European public assessment reports (EPARs) and information on arbitrations and referrals, the Agency will now provide information on the withdrawal by applicants of applications prior to opinion and will produce summaries of EPARs written in a manner that is more understandable to the public.